Pay in 4 interest-free payments of $53.25 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
YM-201636 does not inhibit a type IIγ PtdInsP kinase even at 10 μM and inhibits a mouse type Iα PtdInsP kinase with an IC50>2 μM
an effect that persisted throughout the 14-day infusion
Protosappanin A exerts anti-neuroinflammatory effect by inhibiting JAK2-STAT3 pathway in lipopolysaccharide-induced BV2 microglia
CI-1004 mesylate
Smiles: C[C@@H]1CC[C@H](CC1)C(=O)N([C@@H]1CC[C@@H](O)CC1)C1C=C(C#CC(C)(C)C)SC=1C(O)=O |&1:1
Trastuzumab riciguat YM-201636 does not inhibit aTrastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research. Product information CAS Number: 180288 69 1 Synonym: Anti Human HER2 Humanized Antibody Herceptin Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Solubility: Soluble in DMSO.
US$ 35.00
US$ 10.00
US$ 13.50
US$ 13.50
US$ 13.50